Get in on Milestone Pharmaceuticals Inc’s (MIST) buy-in window today!

With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.74 million shares. The 52-week range on MIST shows that it touched its highest point at $2.75 and its lowest point at $1.12 during that stretch. It currently has a 1-year price target of $10.00. Beta for the stock currently stands at 1.15.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of MIST was down-trending over the past week, with a drop of -8.89%, but this was down by -16.75% over a month. Three-month performance dropped to -12.30% while six-month performance rose 15.49%. The stock lost -2.38% in the past year, while it has lost -30.51% so far this year. A look at the trailing 12-month EPS for MIST yields -0.90 with Next year EPS estimates of -0.99. For the next quarter, that number is -0.16. This implies an EPS growth rate of 54.82% for this year and -57.96% for next year. EPS is expected to grow by 26.29% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -7.22%.

Float and Shares Shorts:

At present, 53.33 million MIST shares are outstanding with a float of 50.76 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for MIST since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.58748 being high and -$0.65839 being low. For MIST, this leads to a yearly average estimate of -$0.628. Based on analyst estimates, the high estimate for the next quarter is -$0.13 and the low estimate is -$0.21. The average estimate for the next quarter is thus -$0.17.

Summary of Insider Activity:

Insiders traded MIST stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.